Cytogenetic and molecular responses were similar irrespective of the presence of the T315I mutation, which confers resistance against imatinib and all second-generation TKIs. 1 Importantly, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback